Pub Date : 2024-06-30eCollection Date: 2024-06-01DOI: 10.18683/germs.2024.1430
Mihaela Cristina Olariu, Mihai Hristu Olariu, Adela Mihaela Iancu, Oana Săndulescu, Anca Streinu-Cercel, Ecaterina Constanţa Barbu, Gülşen Özkaya Şahin, Alina Maria Borcan, Miruna Maria Cruceru, Mădălina Simoiu
Esophageal lesions are common findings in disorders of the digestive tract in patients living with HIV, the most typical symptoms being odynophagia and/or dysphagia. This article provides a narrative review of the spectrum of esophagitis in patients living with HIV, focusing on fungal, viral, bacterial and non-infectious etiologies, as well as co-infections with viral hepatitis viruses. The article provides a comprehensive approach to the strategy of diagnosis and the role of upper digestive endoscopy and histopathological examination in the evaluation of esophageal pathology in patients living with HIV.
{"title":"The spectrum of esophagitis in patients living with HIV - a scoping review.","authors":"Mihaela Cristina Olariu, Mihai Hristu Olariu, Adela Mihaela Iancu, Oana Săndulescu, Anca Streinu-Cercel, Ecaterina Constanţa Barbu, Gülşen Özkaya Şahin, Alina Maria Borcan, Miruna Maria Cruceru, Mădălina Simoiu","doi":"10.18683/germs.2024.1430","DOIUrl":"10.18683/germs.2024.1430","url":null,"abstract":"<p><p>Esophageal lesions are common findings in disorders of the digestive tract in patients living with HIV, the most typical symptoms being odynophagia and/or dysphagia. This article provides a narrative review of the spectrum of esophagitis in patients living with HIV, focusing on fungal, viral, bacterial and non-infectious etiologies, as well as co-infections with viral hepatitis viruses. The article provides a comprehensive approach to the strategy of diagnosis and the role of upper digestive endoscopy and histopathological examination in the evaluation of esophageal pathology in patients living with HIV.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"188-196"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527493/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-30eCollection Date: 2024-06-01DOI: 10.18683/germs.2024.1433
Alina Maria Borcan, Mihaela Cristina Olariu, Elena Liliana Costea, Georgiana Radu, Mădălina Simoiu
Introduction: Aggregatibacter (Actinobacillus) actinomycetemcomitans is a commensal bacterial pathogen in the human oral cavity. It can, however, represent the source of local or systemic infections with serious evolution, in particular infective endocarditis. We present a particular case of an adult male patient with infective endocarditis with A. actinomycetemcomitans and patent ductus arteriosus (PDA).
Case report: A 37-year-old patient, chronic ethanol user, is hospitalized for altered general condition, persistent cough, left chest pain, headache and dizziness, symptoms evolving for about 3 weeks. The clinical examination revealed crackling pulmonary rales present basally bilaterally, as well as numerous cavities and dental abscesses. Chest radiography showed mixed left hiliobasal pneumonia. Chest CT depicted pulmonary abscess and two filling defects in the pulmonary artery trunk, possible thrombotic/vegetative images/mediastinal thrombotic/adenopathic images. Broad spectrum antibiotic treatment was initiated. Transthoracic ultrasonography visualized persistence of ductus arteriosus and an echodense formation attached to the lateral wall of the pulmonary artery trunk. Following positive blood cultures for Aggregatibacter actinomycetemcomitans, the diagnosis of infective endocarditis was established and antibiotic treatment was de-escalated to ceftriaxone according to the antibiogram. The clinical course under treatment was slowly favorable, the patient was discharged on request on day 44 with continued treatment at home.
Conclusions: Infective endocarditis caused by Aggregatibacter actinomycetemcomitans should be considered in patients with altered general condition and congenital cardiovascular defects. In the present case, the patient presented two risk factors, namely poor dental hygiene and PDA.
{"title":"<i>Aggregatibacter actinomycetemcomitans</i> endocarditis in an adult patient with patent ductus arteriosus.","authors":"Alina Maria Borcan, Mihaela Cristina Olariu, Elena Liliana Costea, Georgiana Radu, Mădălina Simoiu","doi":"10.18683/germs.2024.1433","DOIUrl":"10.18683/germs.2024.1433","url":null,"abstract":"<p><strong>Introduction: </strong><i>Aggregatibacter</i> (<i>Actinobacillus</i>) <i>actinomycetemcomitans</i> is a commensal bacterial pathogen in the human oral cavity. It can, however, represent the source of local or systemic infections with serious evolution, in particular infective endocarditis. We present a particular case of an adult male patient with infective endocarditis with <i>A. actinomycetemcomitans</i> and patent ductus arteriosus (PDA).</p><p><strong>Case report: </strong>A 37-year-old patient, chronic ethanol user, is hospitalized for altered general condition, persistent cough, left chest pain, headache and dizziness, symptoms evolving for about 3 weeks. The clinical examination revealed crackling pulmonary rales present basally bilaterally, as well as numerous cavities and dental abscesses. Chest radiography showed mixed left hiliobasal pneumonia. Chest CT depicted pulmonary abscess and two filling defects in the pulmonary artery trunk, possible thrombotic/vegetative images/mediastinal thrombotic/adenopathic images. Broad spectrum antibiotic treatment was initiated. Transthoracic ultrasonography visualized persistence of ductus arteriosus and an echodense formation attached to the lateral wall of the pulmonary artery trunk. Following positive blood cultures for <i>Aggregatibacter actinomycetemcomitans</i>, the diagnosis of infective endocarditis was established and antibiotic treatment was de-escalated to ceftriaxone according to the antibiogram. The clinical course under treatment was slowly favorable, the patient was discharged on request on day 44 with continued treatment at home.</p><p><strong>Conclusions: </strong>Infective endocarditis caused by <i>Aggregatibacter actinomycetemcomitans</i> should be considered in patients with altered general condition and congenital cardiovascular defects. In the present case, the patient presented two risk factors, namely poor dental hygiene and PDA.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"210-215"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527487/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: The rise in antimicrobial resistance among bacterial pathogens is a global concern, and anti-virulence therapy may be an alternative strategy to address the issue. Multidrug resistant (MDR) hypervirulent Klebsiella pneumoniae (HvKp) is known to be associated with healthcare associated infections. These are often challenging to treat and here anti-virulence therapy may be a treatment option. The study of anti-virulence compounds against HvKp by in-silico prediction, in-vitro experiments and in-vivo assay enables to determine which anti-virulence compounds are suitable for an alternative approach MDR HvKp.
Methods: Modeling of the proteins, ligand binding and molecular docking were performed targeting different hypervirulence genes viz., rmpA, rmpA2 and, iroC by in-silico analysis using different bioinformatics tool and software. Minimum inhibitory concentration (MIC) was determined for six anti-virulence compounds; curcumin, eugenol, reserpine, linoleic acid, ε-anethole, and α-thujone by standard protocol. Quantitative real-time PCR was performed selecting two isolates harboring rmpA, rmpA2 and iroC genes. Galleria mellonella larva killing assay was used for in-vivo experiment.
Results: In-silico analysis observed that linoleic acid could be the best fit in comparison with the other compounds. None of the anti-virulence compounds showed any inhibitory activity and upon transcriptional expression analysis of the hypervirulence genes; rmpA was marginally increased for both the isolates when linoleic acid exposure was given.
Conclusions: In-vivo study revealed that linoleic acid and reserpine showed anti-virulence activity.
{"title":"Linoleic acid acts as a potential anti-virulence agent in <i>Klebsiella pneumoniae</i>.","authors":"Jayalaxmi Wangkheimayum, Tuhina Banerjee, Somorita Baishya, Swati Sharma, Manabendra Dutta Choudhury, Monjur Ahmed Laskar, Amitabha Bhattacharjee","doi":"10.18683/germs.2024.1426","DOIUrl":"10.18683/germs.2024.1426","url":null,"abstract":"<p><strong>Introduction: </strong>The rise in antimicrobial resistance among bacterial pathogens is a global concern, and anti-virulence therapy may be an alternative strategy to address the issue. Multidrug resistant (MDR) hypervirulent <i>Klebsiella pneumoniae</i> (HvKp) is known to be associated with healthcare associated infections. These are often challenging to treat and here anti-virulence therapy may be a treatment option. The study of anti-virulence compounds against HvKp by in-silico prediction, in-vitro experiments and in-vivo assay enables to determine which anti-virulence compounds are suitable for an alternative approach MDR HvKp.</p><p><strong>Methods: </strong>Modeling of the proteins, ligand binding and molecular docking were performed targeting different hypervirulence genes viz., <i>rmpA</i>, <i>rmpA2</i> and, <i>iroC</i> by in-silico analysis using different bioinformatics tool and software. Minimum inhibitory concentration (MIC) was determined for six anti-virulence compounds; curcumin, eugenol, reserpine, linoleic acid, ε-anethole, and α-thujone by standard protocol. Quantitative real-time PCR was performed selecting two isolates harboring <i>rmpA, rmpA2</i> and <i>iroC</i> genes. <i>Galleria mellonella</i> larva killing assay was used for in-vivo experiment.</p><p><strong>Results: </strong>In-silico analysis observed that linoleic acid could be the best fit in comparison with the other compounds. None of the anti-virulence compounds showed any inhibitory activity and upon transcriptional expression analysis of the hypervirulence genes; <i>rmpA</i> was marginally increased for both the isolates when linoleic acid exposure was given.</p><p><strong>Conclusions: </strong>In-vivo study revealed that linoleic acid and reserpine showed anti-virulence activity.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"136-148"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-30eCollection Date: 2024-06-01DOI: 10.18683/germs.2024.1428
Basil Alawyia, Sarah Fathima, Nikolaos Spernovasilis, Danny Alon-Ellenbogen
Introduction: Antimicrobial resistance (AMR) is among the greatest threats to global healthcare. The World Health Organization (WHO) estimates that by 2050 ten million deaths will be attributed to AMR annually. In response, the WHO has implemented antibiotic stewardship programs which focus on optimizing antibiotic use and raise, amongst others, the issue of the preferred method of intravenous antibiotic administration. Various studies have attempted to answer this question with conflicting results.
Review: This review examined several studies assessing extended/continuous infusion compared to intermittent infusion of three beta-lactams: piperacillin-tazobactam, cefepime, and meropenem. The findings and conclusions of each study were summarized and compared to one another to provide a general overview of the current evidence.
Conclusions: We conclude that continuous/extended infusion showed a greater clinical benefit in highly critical cases, namely sepsis and febrile neutropenia, compared to intermittent infusion. Additionally, in cases where a pathogen was identified, continuous/extended infusion showed superiority. Nonetheless, high-quality studies with larger samples are needed to demonstrate the difference between these two modes of infusion in a way that would better inform guidelines and policies, aiding in the fight against AMR.
{"title":"Continuous versus intermittent infusion of beta-lactam antibiotics: where do we stand today? A narrative review.","authors":"Basil Alawyia, Sarah Fathima, Nikolaos Spernovasilis, Danny Alon-Ellenbogen","doi":"10.18683/germs.2024.1428","DOIUrl":"10.18683/germs.2024.1428","url":null,"abstract":"<p><strong>Introduction: </strong>Antimicrobial resistance (AMR) is among the greatest threats to global healthcare. The World Health Organization (WHO) estimates that by 2050 ten million deaths will be attributed to AMR annually. In response, the WHO has implemented antibiotic stewardship programs which focus on optimizing antibiotic use and raise, amongst others, the issue of the preferred method of intravenous antibiotic administration. Various studies have attempted to answer this question with conflicting results.</p><p><strong>Review: </strong>This review examined several studies assessing extended/continuous infusion compared to intermittent infusion of three beta-lactams: piperacillin-tazobactam, cefepime, and meropenem. The findings and conclusions of each study were summarized and compared to one another to provide a general overview of the current evidence.</p><p><strong>Conclusions: </strong>We conclude that continuous/extended infusion showed a greater clinical benefit in highly critical cases, namely sepsis and febrile neutropenia, compared to intermittent infusion. Additionally, in cases where a pathogen was identified, continuous/extended infusion showed superiority. Nonetheless, high-quality studies with larger samples are needed to demonstrate the difference between these two modes of infusion in a way that would better inform guidelines and policies, aiding in the fight against AMR.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"162-178"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Non-tuberculous mycobacterial (NTM) disease is an underdiagnosed condition that usually manifests as pulmonary infection. Extrapulmonary manifestations are rare and can be easily overlooked or misdiagnosed as tuberculosis or malignancy.
Case report: Herein, we present four cases of extrapulmonary NTM disease in immunocompetent patients. Patient 1 had bone marrow suppression secondary to NTM infection. Patient 2 was diagnosed with Mycobacterium abscessus meningitis, brain abscess and arachnoiditis. Patient 3 had pleural effusion, and fluid cytology revealed Mycobacterium fortuitum. Patient 4 was a 30-year-old male with cervical lymphadenopathy due to NTM. Two patients (case 2 and case 4) were initially diagnosed with tuberculosis but showed no response to anti-tubercular drugs. One patient (case 3) died within seven days of initiation of treatment. The rest of the patients (cases 1 and 2) showed clinical improvement with antimicrobial therapy for NTM species. Case 4 responded well to surgical excision without the need for antibiotics.
Conclusions: Clinicians should be vigilant about the possibility of NTM disease. Early diagnosis is vital to prevent poor outcomes, particularly in the setting of disseminated infections.
{"title":"Clinical spectrum of extrapulmonary non-tuberculous mycobacterial disease in immunocompetent patients: a case series.","authors":"Prakrati Yadav, Durga Shankar Meena, Deepak Kumar, Nikhil John, Navneet Kaur, Sarika Kombade, Gopal Krishana Bohra, Sarvesh Tiwari, Vijaylaxmi Nag","doi":"10.18683/germs.2024.1431","DOIUrl":"10.18683/germs.2024.1431","url":null,"abstract":"<p><strong>Introduction: </strong>Non-tuberculous mycobacterial (NTM) disease is an underdiagnosed condition that usually manifests as pulmonary infection. Extrapulmonary manifestations are rare and can be easily overlooked or misdiagnosed as tuberculosis or malignancy.</p><p><strong>Case report: </strong>Herein, we present four cases of extrapulmonary NTM disease in immunocompetent patients. Patient 1 had bone marrow suppression secondary to NTM infection. Patient 2 was diagnosed with <i>Mycobacterium abscessus</i> meningitis, brain abscess and arachnoiditis. Patient 3 had pleural effusion, and fluid cytology revealed <i>Mycobacterium fortuitum</i>. Patient 4 was a 30-year-old male with cervical lymphadenopathy due to NTM. Two patients (case 2 and case 4) were initially diagnosed with tuberculosis but showed no response to anti-tubercular drugs. One patient (case 3) died within seven days of initiation of treatment. The rest of the patients (cases 1 and 2) showed clinical improvement with antimicrobial therapy for NTM species. Case 4 responded well to surgical excision without the need for antibiotics.</p><p><strong>Conclusions: </strong>Clinicians should be vigilant about the possibility of NTM disease. Early diagnosis is vital to prevent poor outcomes, particularly in the setting of disseminated infections.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"197-203"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-30eCollection Date: 2024-06-01DOI: 10.18683/germs.2024.1425
Robert Hohan, Ovidiu Vlaicu, Leontina Bănică, Andreea Ioana Tudor, Anca Negru, Simona Paraschiv, Dan Oţelea
Introduction: To better understand the factors which influence the spread of monkeypox (mpox) infection, the patients that tested positive for mpox virus by real-time PCR in one of the main infectious diseases centers in Bucharest were analyzed in this study, amounting to one third of the confirmed cases in Romania.
Methods: Clinical data and laboratory tests were used to build the patient profiles. In the case of positive mpox results, next-generation sequencing of the viral genome was also performed to better comprehend the epidemiology of the infections and the evolutionary path of this virus.
Results: Among 47 patients with clinical suspicion of infection, 18 cases tested positive for mpox by real-time PCR (RT-PCR). Patients were mainly men who have sex with men (MSM), often coinfected with HIV-1 (half of the cases) and presenting with other sexually transmitted infections (STIs). Phylogenetic analysis was performed on 20 samples (15 patients) and indicated that mpox cases in Romania were the result of multiple importing events followed by local spread. A few sequences from European countries (Germany, Italy, France) and USA were found to be closely related to the Romanian sequences. Intra-host evolution was observed and documented in one patient with HIV-1 infection with uncontrolled viremia, showing slightly different mutation profiles in two body compartments.
Conclusions: This study showed that the mpox cases from Romania presented similar clinical, epidemiological and mutational features with those reported by other European countries.
{"title":"Clinical, epidemiological and molecular aspects of patients with mpox in Romania.","authors":"Robert Hohan, Ovidiu Vlaicu, Leontina Bănică, Andreea Ioana Tudor, Anca Negru, Simona Paraschiv, Dan Oţelea","doi":"10.18683/germs.2024.1425","DOIUrl":"10.18683/germs.2024.1425","url":null,"abstract":"<p><strong>Introduction: </strong>To better understand the factors which influence the spread of monkeypox (mpox) infection, the patients that tested positive for mpox virus by real-time PCR in one of the main infectious diseases centers in Bucharest were analyzed in this study, amounting to one third of the confirmed cases in Romania.</p><p><strong>Methods: </strong>Clinical data and laboratory tests were used to build the patient profiles. In the case of positive mpox results, next-generation sequencing of the viral genome was also performed to better comprehend the epidemiology of the infections and the evolutionary path of this virus.</p><p><strong>Results: </strong>Among 47 patients with clinical suspicion of infection, 18 cases tested positive for mpox by real-time PCR (RT-PCR). Patients were mainly men who have sex with men (MSM), often coinfected with HIV-1 (half of the cases) and presenting with other sexually transmitted infections (STIs). Phylogenetic analysis was performed on 20 samples (15 patients) and indicated that mpox cases in Romania were the result of multiple importing events followed by local spread. A few sequences from European countries (Germany, Italy, France) and USA were found to be closely related to the Romanian sequences. Intra-host evolution was observed and documented in one patient with HIV-1 infection with uncontrolled viremia, showing slightly different mutation profiles in two body compartments.</p><p><strong>Conclusions: </strong>This study showed that the mpox cases from Romania presented similar clinical, epidemiological and mutational features with those reported by other European countries.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"126-135"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527485/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Although Pseudomonas aeruginosa (PA) hasn't been considered as a recognized agent of diarrhea, this organism is able to cause community-acquired diarrhea accompanied by fever and sepsis, as well as antibiotic-associated diarrhea (AAD). Antibiotic resistance rates in stool isolates of PA are generally lower compared to other infection sites, but in patients with AAD, there are reports of resistance to most of the antibiotic classes in these isolates. PA, along with other opportunistic pathogens like Clostridioides difficile, can cause AAD. Therefore, it is suggested to examine stool samples of patients with predisposing factors such as intensive care unit (ICU) admission and long-time antibiotic treatment, especially with cephalosporins, for both C. difficile and PA.
虽然铜绿假单胞菌(PA)尚未被认为是公认的腹泻病原体,但这种病菌可引起伴有发热和败血症的社区获得性腹泻,以及抗生素相关性腹泻(AAD)。与其他感染部位相比,PA粪便分离株的抗生素耐药率通常较低,但在AAD患者中,有报告称这些分离株对大多数抗生素类产生了耐药性。PA 与艰难梭状芽孢杆菌等其他机会性病原体可导致 AAD。因此,建议对具有易感因素(如入住重症监护病房(ICU)和长期抗生素治疗(尤其是头孢菌素类))的患者的粪便样本进行艰难梭菌和 PA 的检查。
{"title":"The emerging role of <i>Pseudomonas aeruginosa</i> in diarrhea: where we stand.","authors":"Mansoor Khaledi, Ahdiyeh Saghabashi, Hossein Ghahramanpour","doi":"10.18683/germs.2024.1429","DOIUrl":"10.18683/germs.2024.1429","url":null,"abstract":"<p><p>Although <i>Pseudomonas aeruginosa</i> (PA) hasn't been considered as a recognized agent of diarrhea, this organism is able to cause community-acquired diarrhea accompanied by fever and sepsis, as well as antibiotic-associated diarrhea (AAD). Antibiotic resistance rates in stool isolates of PA are generally lower compared to other infection sites, but in patients with AAD, there are reports of resistance to most of the antibiotic classes in these isolates. PA, along with other opportunistic pathogens like <i>Clostridioides difficile</i>, can cause AAD. Therefore, it is suggested to examine stool samples of patients with predisposing factors such as intensive care unit (ICU) admission and long-time antibiotic treatment, especially with cephalosporins, for both <i>C. difficile</i> and PA.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"179-188"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-30eCollection Date: 2024-06-01DOI: 10.18683/germs.2024.1432
Gheorghiţă Jugulete, Maria Mădălina Merişescu, Carmen Pavelescu, Monica Luminiţa Luminos
Introduction: Streptococcus pneumoniae is one of the associated bacteria that can cause the rare but high mortality hematological pathology known as purpura fulminans (PF) in both adults and children. Pediatric patients with PF can progress quickly to sepsis and multiorgan failure, especially immunocompromised individuals and young children. Due to the thrombotic blockage of blood arteries in PF, there is diffuse intravascular thrombosis and hemorrhagic infarction of the skin, which evolves from ecchymosis to skin necrosis, risk of limb sequelae, sepsis and fatality.
Case report: We present a case of a previously healthy 1-year and 9-months old female who was admitted to the Intensive Care Unit of the National Institute of Infectious Diseases "Prof. Dr. Matei Balş"- Bucharest, Romania. On physical examination, she was febrile, hypotensive, tachycardic, and had erythematous patches on her left upper limb and trunk. Initial blood work was significant for creatinine 4.45 mg/dL, aspartate aminotransferase 112 U/L, alanine aminotransferase 130 U/L and fibrinogen 596 mg/dL. Hematological workup showed a white blood cells count of 34 × 109/L, hemoglobin 9.7 g/dL, platelets 23000/L, D-dimers 89000 μg/L, and elevated PT and aPTT. Broad-spectrum antibiotics vancomycin and ceftriaxone were administrated. A lumbar puncture was performed for cerebrospinal fluid (CSF) analysis and culture grew Streptococcus pneumoniae serotype 1A. She required peritoneal dialysis due to acute kidney injury (AKI) and surgeries for affected skin areas. After multiple organ system failures, our patient evolved rapidly to irreversible tissue necrosis and death.
Conclusions: We aim to report a rare case of PF associated with pneumococcal meningoencephalitis in an immunocompetent child, to better appreciate the risk of fatal evolution when managing this disease in children.
{"title":"Rare fatal case of purpura fulminans due to pneumococcal sepsis in a child, associated with multiorgan failure.","authors":"Gheorghiţă Jugulete, Maria Mădălina Merişescu, Carmen Pavelescu, Monica Luminiţa Luminos","doi":"10.18683/germs.2024.1432","DOIUrl":"10.18683/germs.2024.1432","url":null,"abstract":"<p><strong>Introduction: </strong><i>Streptococcus pneumoniae</i> is one of the associated bacteria that can cause the rare but high mortality hematological pathology known as purpura fulminans (PF) in both adults and children. Pediatric patients with PF can progress quickly to sepsis and multiorgan failure, especially immunocompromised individuals and young children. Due to the thrombotic blockage of blood arteries in PF, there is diffuse intravascular thrombosis and hemorrhagic infarction of the skin, which evolves from ecchymosis to skin necrosis, risk of limb sequelae, sepsis and fatality.</p><p><strong>Case report: </strong>We present a case of a previously healthy 1-year and 9-months old female who was admitted to the Intensive Care Unit of the National Institute of Infectious Diseases \"Prof. Dr. Matei Balş\"- Bucharest, Romania. On physical examination, she was febrile, hypotensive, tachycardic, and had erythematous patches on her left upper limb and trunk. Initial blood work was significant for creatinine 4.45 mg/dL, aspartate aminotransferase 112 U/L, alanine aminotransferase 130 U/L and fibrinogen 596 mg/dL. Hematological workup showed a white blood cells count of 34 × 10<sup>9</sup>/L, hemoglobin 9.7 g/dL, platelets 23000/L, D-dimers 89000 μg/L, and elevated PT and aPTT. Broad-spectrum antibiotics vancomycin and ceftriaxone were administrated. A lumbar puncture was performed for cerebrospinal fluid (CSF) analysis and culture grew <i>Streptococcus pneumoniae</i> serotype 1A. She required peritoneal dialysis due to acute kidney injury (AKI) and surgeries for affected skin areas. After multiple organ system failures, our patient evolved rapidly to irreversible tissue necrosis and death.</p><p><strong>Conclusions: </strong>We aim to report a rare case of PF associated with pneumococcal meningoencephalitis in an immunocompetent child, to better appreciate the risk of fatal evolution when managing this disease in children.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"204-209"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Infective endocarditis (IE) is a disease that may frequently lead to significant morbidity and is associated with high mortality rates. Even though IE is classically caused by Gram-positive bacteria, Gram-negative bacteria may seldom cause IE. Antimicrobial resistance (AMR) may pose significant problems in treating IE, especially for carbapenem-resistant pathogens. This study aimed to review all cases of IE by carbapenem-resistant Gram-negative bacteria in a systematic way and present information on epidemiology, clinical findings, treatment, and outcomes.
Methods: A systematic review of PubMed, Cochrane Library, and Scopus (all published studies up to 6 August 2023) for published studies providing information on epidemiology, clinical findings, treatment, and outcomes of IE by carbapenem-resistant Gram-negative bacteria was performed.
Results: A total of 24 studies containing data from 26 patients were included. Among all patients, 53.9% were male, and the median age was 66 years. Among all patients, 38.5% had a history of a prosthetic valve. The most commonly affected valve was the aortic, followed by the mitral valve. Fever, sepsis, emboli, and shock were the most frequent clinical findings. The most commonly isolated pathogens were Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii. Aminoglycosides, colistin, cephalosporins, and carbapenems were the most commonly used antimicrobials. Surgery was performed in 53.8% of patients. Mortality was 38.5%.
Conclusions: The development of infection control measures and antimicrobial stewardship interventions is needed to reduce the spread of AMR and the likelihood of this fatal infection.
{"title":"Infective endocarditis by carbapenem-resistant Gram-negative bacteria - a systematic review.","authors":"Konstantinos Pitsikakis, Michail Skandalakis, Konstantinos Fragkiadakis, Stella Baliou, Petros Ioannou","doi":"10.18683/germs.2024.1427","DOIUrl":"10.18683/germs.2024.1427","url":null,"abstract":"<p><strong>Introduction: </strong>Infective endocarditis (IE) is a disease that may frequently lead to significant morbidity and is associated with high mortality rates. Even though IE is classically caused by Gram-positive bacteria, Gram-negative bacteria may seldom cause IE. Antimicrobial resistance (AMR) may pose significant problems in treating IE, especially for carbapenem-resistant pathogens. This study aimed to review all cases of IE by carbapenem-resistant Gram-negative bacteria in a systematic way and present information on epidemiology, clinical findings, treatment, and outcomes.</p><p><strong>Methods: </strong>A systematic review of PubMed, Cochrane Library, and Scopus (all published studies up to 6 August 2023) for published studies providing information on epidemiology, clinical findings, treatment, and outcomes of IE by carbapenem-resistant Gram-negative bacteria was performed.</p><p><strong>Results: </strong>A total of 24 studies containing data from 26 patients were included. Among all patients, 53.9% were male, and the median age was 66 years. Among all patients, 38.5% had a history of a prosthetic valve. The most commonly affected valve was the aortic, followed by the mitral valve. Fever, sepsis, emboli, and shock were the most frequent clinical findings. The most commonly isolated pathogens were <i>Pseudomonas aeruginosa, Klebsiella pneumoniae,</i> and <i>Acinetobacter baumannii</i>. Aminoglycosides, colistin, cephalosporins, and carbapenems were the most commonly used antimicrobials. Surgery was performed in 53.8% of patients. Mortality was 38.5%.</p><p><strong>Conclusions: </strong>The development of infection control measures and antimicrobial stewardship interventions is needed to reduce the spread of AMR and the likelihood of this fatal infection.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 2","pages":"149-161"},"PeriodicalIF":1.7,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11527486/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142568882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-31eCollection Date: 2024-03-01DOI: 10.18683/germs.2024.1414
Amit K Rai, Ragini Tilak, Punit Tiwari, Pooja Meena, Ashok Kumar, Atul K Tiwari, Munesh K Gupta
Introduction: Neonatal candidemia is a life-threatening event in babies requiring ICU admission. Prompt diagnosis and appropriate treatment reduce mortality and morbidity. Worldwide, there is an emergence of drug-resistant rare Candida species causing neonatal sepsis that necessitates antifungal susceptibility testing in each case.
Methods: We did a prospective study to isolate Candida species causing neonatal sepsis and to determine the predisposing risk factors and time to positivity for flagged positivity. We also determined fluconazole, itraconazole and amphotericin B minimum inhibitory concentration (MIC) against isolated Candida species by broth microdilution method using CLSI M27-A3 guidelines.
Results: A total of 107 neonatal candidemia events were noted. Prematurity was the most common predisposing risk factor. Most isolates were non-albicans Candida. Candida utilis, C. pelliculosa, C. tropicalis and K. ohmeri were the predominant fungi causing neonatal candidemia. A varied antifungal MIC against isolated Candida species was noted. However, 90% of the isolated Candida strains had <8 µg/mL fluconazole MIC. Moreover, ≥8 and ≥2 µg/mL MIC for fluconazole and amphotericin B respectively were also noted.
Conclusions: Rare Candida species having varied fluconazole and amphotericin B MIC cause neonatal candidemia. Therefore, culture isolation and antifungal susceptibility testing should be done in each case of neonatal candidemia.
简介新生儿念珠菌血症对需要入住重症监护室的婴儿来说是一种威胁生命的疾病。及时诊断和适当治疗可降低死亡率和发病率。在全球范围内,引起新生儿败血症的罕见念珠菌出现了耐药性,因此有必要对每个病例进行抗真菌药敏试验:我们进行了一项前瞻性研究,以分离导致新生儿败血症的念珠菌菌种,并确定标记阳性的易感危险因素和阳性时间。我们还根据 CLSI M27-A3 指南,采用肉汤微稀释法测定了氟康唑、伊曲康唑和两性霉素 B 对分离念珠菌的最低抑菌浓度(MIC):结果:共发现 107 例新生儿念珠菌血症。早产是最常见的诱发风险因素。大多数分离株为非白色念珠菌。引起新生儿念珠菌血症的主要真菌是白色念珠菌(Candida utilis)、白色念珠菌(C. pelliculosa)、热带念珠菌(C. tropicalis)和白色念珠菌(K. ohmeri)。针对分离出的念珠菌的抗真菌 MIC 值各不相同。然而,90%的分离念珠菌菌株都有结论:罕见的念珠菌菌株具有不同的氟康唑和两性霉素 B MIC,可导致新生儿念珠菌血症。因此,应针对每例新生儿念珠菌病进行培养分离和抗真菌药敏试验。
{"title":"Emergence of rare and uncommon yeast-like pathogens causing neonatal sepsis at a tertiary care center, North India.","authors":"Amit K Rai, Ragini Tilak, Punit Tiwari, Pooja Meena, Ashok Kumar, Atul K Tiwari, Munesh K Gupta","doi":"10.18683/germs.2024.1414","DOIUrl":"10.18683/germs.2024.1414","url":null,"abstract":"<p><strong>Introduction: </strong>Neonatal candidemia is a life-threatening event in babies requiring ICU admission. Prompt diagnosis and appropriate treatment reduce mortality and morbidity. Worldwide, there is an emergence of drug-resistant rare <i>Candida</i> species causing neonatal sepsis that necessitates antifungal susceptibility testing in each case.</p><p><strong>Methods: </strong>We did a prospective study to isolate <i>Candida</i> species causing neonatal sepsis and to determine the predisposing risk factors and time to positivity for flagged positivity. We also determined fluconazole, itraconazole and amphotericin B minimum inhibitory concentration (MIC) against isolated <i>Candida</i> species by broth microdilution method using CLSI M27-A3 guidelines.</p><p><strong>Results: </strong>A total of 107 neonatal candidemia events were noted. Prematurity was the most common predisposing risk factor. Most isolates were non-<i>albicans Candida</i>. <i>Candida utilis</i>, <i>C. pelliculosa, C. tropicalis</i> and <i>K. ohmeri</i> were the predominant fungi causing neonatal candidemia. A varied antifungal MIC against isolated <i>Candida</i> species was noted. However, 90% of the isolated <i>Candida</i> strains had <8 µg/mL fluconazole MIC. Moreover, ≥8 and ≥2 µg/mL MIC for fluconazole and amphotericin B respectively were also noted.</p><p><strong>Conclusions: </strong>Rare <i>Candida</i> species having varied fluconazole and amphotericin B MIC cause neonatal candidemia. Therefore, culture isolation and antifungal susceptibility testing should be done in each case of neonatal candidemia.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"14 1","pages":"20-27"},"PeriodicalIF":1.7,"publicationDate":"2024-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11333843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}